Influenza vaccination: Is it appropriate in chronic fatigue syndrome?

American Journal of Respiratory Medicine

Volumn 1, Issue 1, 2002, Pages 3-9

  Sleigh, Kenna M ^a   Marra, Fawziah H ^b   Stiver, H Grant ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DISODIUM HYDROGEN PHOSPHATE; EGG PROTEIN; FLUVIRAL S F; GENTAMICIN; INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE; LIVE VACCINE; NEOMYCIN; PARACETAMOL; PLACEBO; POLYMYXIN; POLYSORBATE 80; POTASSIUM CHLORIDE; POTASSIUM DIHYDROGEN PHOSPHATE; PROPIOLACTONE; SODIUM CHLORIDE; THIOMERSAL; TRIBUTYL PHOSPHATE; TRITON X 100; TRIVALENT; WATER;

ALLERGIC ASTHMA; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANOREXIA; ANTIBODY TITER; CHRONIC FATIGUE SYNDROME; DATA ANALYSIS; DISEASE EXACERBATION; DRUG HYPERSENSITIVITY; DRUG SAFETY; EDEMA; FEVER; GUILLAIN BARRE SYNDROME; HEADACHE; HUMAN; IMMUNE SYSTEM; IMMUNIZATION; INFLUENZA; INFLUENZA VACCINATION; INJECTION SITE; MALAISE; MYALGIA; NAUSEA AND VOMITING; PATHOPHYSIOLOGY; PATIENT ATTITUDE; PATIENT EDUCATION; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SAMPLE; SKIN INDURATION; SKIN MANIFESTATION; URTICARIA;

EID: 0041385776     PISSN: 11756365     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03257157     Document Type: Review

References (37)

1. Buchwald D, Umali P, Umali J, et al. Chronic fatigue and the chronic fatigue syndrome: Prevalence in a Pacific Northwest health care system. Ann Intern Med 1995; 123: 81-8
2. Fukuda K, Straus S, Hickie L, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994; 121: 953-9
3. Demitrack MA. Chronic fatigue syndrome: a disease of the hypothalamic-pituitary-adrenal axis? Ann Med 1994; 26: 1-5
4. Wessely S, Butler S, Chalder T, et al. The cognitive-behavioural management of post-viral syndrome. In: Jennings R, Mowbray RJ, editors. Post-viral fatigue syndrome. Chichester: Wiley, 1991: 305-34
5. Mawle AC, Nisenbaum R, Dobbins JG, et al. Immune responses associated with chronic fatigue syndrome: a case-control study. J Infect Dis 1997; 175: 136-41
6. Gupta S. Vayuvegula B. A comprehensive immunological analysis in chronic fatigue syndrome. Scand J Immunol 1991; 33: 319-27
7. Nichol KI, Mendelman PM, Mallon KP, et al. Effectiveness of live, attenuated intranasal influenza vaccine in healthy, working adults. JAMA 2000; 282: 137-44
8. Belshe RB, Mendelman PM Treanor J, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children. N Engl J Med 1998; 338: 1405-12
9. Meikljohn G. Effectiveness of monovalent influenza A-prime vaccine during 1957 influenza A-prime epidemic. Am J Hyg 1958; 67: 237-49
10. Govaert TME, Thijs CTMCN, Masurel N, et al. The efficacy of influenza vaccination in elderly people: a randomized, double-blind, placebo-controlled trial. JAMA 1994; 272: 1661-5
11. Stiver HG, Graves P. Eickhoff TC, et al. Efficacy of 'Hong Kong' vaccine in preventing 'England' variant influenza A in 1972. N Engl J Med 1973; 289: 1267-71
12. Meikljohn G, Eickhoff TC, Graves P, et al. Antigenic drift and efficacy of influenza vaccines, 1976-1977. J Infect Dis 1978; 138: 618-24
13. Belshe RB, Gruber WC, Mendelman PM, et al. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr 2000; 136: 139-41
14. Govaert ME, Dinant GJ, Aretz K, et al. Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial. BMJ 1993; 307: 988-90
15. Margolis KL, Nichol KL, Poland GA, et al. Frequency of adverse reactions to influenza vaccine in the elderly: a randomized, placebo-controlled trial. JAMA 1990; 264: 1139-41
16. Nichol KL, Margolis KL, Lind A, et al. Side effects associated with influenza vaccination in healthy working adults: a randomized, placebo-controlled trial. Arch Intern Med 1996; 156: 1546-50
17. Scheifele DW, Bjornson G, Johnson J. Evaluation of adverse events after influenza vaccination in hospital personnel. CMAJ 1990; 142: 127-30
18. Barry DW, Mayner RE, Hochstein HD, et al. Comparative trial of influenza vaccines II. Adverse reactions in children and adults. Am J Epidemiol 1976; 104: 47-59
19. Bierman CW, Shapiro GG, Pierson WE, et al. Safety of influenza vaccination in allergic children. J Infect Dis 1997; 136: S652-5
20. Aberer W. Vaccination despite thimerosal sensitivity. Contact Derm 1991; 24: 6-10
21. Ropper AH. Guillain-Barré syndrome. N Engl J Med 1992; 326: 1130-6
22. Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, et al. Guillain-Barré syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. Am J Epidemiol 1979; 110: 105-23
23. Safranek TJ, Lawrence DN, Kurland LT, et al. Reassessment of the association between Guillain-Barré syndrome and receipt of swine influenza vaccine in 1976-1977: results of a two-state study. Expert Neurology Group. Am J Epidemiol 1991; 133: 940-51
24. Reyes M, Gary Jr HE, Dobbins JG, et al. Surveillance for chronic fatigue syndrome - four U.S. cities, September 1989 through August 1993. MMWR Morb Mortal Weekly Rep 1997; 46 (SS-2): 1-13
25. Heimberger T, Chang H-G, Shaikh M, et al. Knowledge and attitudes of healthcare workers about influenza: why are they not getting vaccinated? Inf Con Hosp Epi 1995; 16 (7): 412-5
26. Weinman J, Petrie KJ, Moss-Morris R, et al. The illness perception questionnaire: a new method for assessing the cognitive representation of illness. Psychol Health 1996; 11: 431-45
27. Mechanic D. Sociological dimensions of illness behaviour. Soc Sci Med 1995; 41 (91): 1207-16
28. Sleigh KM, Danforth DG, Hall RT, et al. Double-blind, randomized study of the effects of influenza vaccination on the specific antibody response and clinical course of patients with chronic fatigue syndrome. Can J Infect Dis 2000; 11 (5): 267-73
29. CCDR. Report of the Working Group on the Possible Relationship between Hepatitis B Vaccination and the Chronic Fatigue Syndrome. CMA J 1993; 149 (3): 314-9
30. Vedhara K, Llewelyn MB, Fox JD, et al. Consequences of live poliovirus vaccine administration in chronic fatigue syndrome. J Neurol 1997; 75: 183-95
31. Glaser R, Kiecolt-Glaser JK, Malarkey WB, et al. The influence of psychological stress on the immune response to vaccines. Ann N Y Acad Sci 1998; 840: 649-55
32. Natelson BH, Ye N, Moul DE, et al. High titers of anti-Epstein-Barr virus DNA polymerase are found in patients with severe fatiguing illness. J Med Virol 1994; 42: 42-6
33. Jones JF, Williams M, Schooley RT, et al. Antibodies to Epstein-Barr-specific Dnase and DNA polymerase in the chronic fatigue syndrome. Arch Intern Med 1988; 148: 1957-60
34. Wallace II HL, Natelson B, Gause W, et al. Human herpesviruses in chronic fatigue syndrome. Clin Diagn Lab Immunol 1999; 6 (2): 216-23
35. Glaser R, Kiecolt-Glaser JK. stress-associated immune-modulation: relevance to viral infections and chronic fatigue syndrome. Am J Med 1998: 42S
36. Buchwald D, Ashley RL, Pearlman T, et al. Viral serologies in patients with chronic fatigue and chronic fatigue syndrome. J Med Virol 1996; 50 (1): 25-30
37. Derogatis L. SCL-90-R administration, scoring, and interpretation manual-II. Towson (MD): Clinical Psychometric Research, 1983